DV Biomed Co., Ltd. (TPEX:6539)
Taiwan · Delayed Price · Currency is TWD 59.00
+1.50 (2.61%)
At close: Feb 11, 2026
DV Biomed Market Cap
DV Biomed has a market cap or net worth of 1.44 billion as of February 13, 2026. Its market cap has increased by 6.94% in one year.
Market Cap
1.44B
Enterprise Value
1.17B
Revenue
712.61M
Ranking
n/a
PE Ratio
28.61
Stock Price
59.00
Market Cap Chart
Since October 15, 2015, DV Biomed's market cap has decreased from 5.01B to 1.44B, a decrease of -71.31%. That is a compound annual growth rate of -11.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.44B | - |
| Dec 31, 2025 | 1.44B | 11.93% |
| Dec 30, 2024 | 1.28B | -55.96% |
| Dec 29, 2023 | 2.91B | -11.33% |
| Dec 30, 2022 | 3.29B | -5.52% |
| Dec 30, 2021 | 3.48B | -17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allied Biotech | 2.35B |
| TSH Biopharm Corporation | 2.17B |
| GeneFerm Biotechnology | 1.81B |
| Tien Liang BioTech | 1.75B |
| InnoPharmax | 1.72B |
| Winston Medical Supply | 1.50B |
| Excelsior Biopharma | 1.24B |
| Mediera | 1.07B |